Wound Care (Pharmacies) - Cyprus

  • Cyprus
  • Revenue in the Wound Care market is projected to reach US$0.41m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of -1.24%, resulting in a market volume of US$0.39m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.32 are generated in 2024.

Key regions: South Korea, United States, Canada, United Kingdom, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Cyprus has been experiencing steady growth in recent years, driven by increasing customer preferences for convenient and accessible healthcare products. Customer preferences in the Wound Care (Pharmacies) market in Cyprus have been shifting towards products that are easily available and can be purchased without a prescription. This trend is in line with the global market, where consumers are seeking self-care options and are more inclined to visit pharmacies for minor healthcare needs. The convenience of purchasing wound care products directly from pharmacies allows customers to quickly address their healthcare concerns without the need for a doctor's appointment or a visit to a hospital. In addition to convenience, customers in Cyprus are also placing a greater emphasis on the quality and effectiveness of wound care products. They are more likely to choose products that are recommended by healthcare professionals or have a proven track record of success. This preference for quality and efficacy is driving the demand for innovative wound care solutions, such as advanced dressings and wound healing technologies. The Wound Care (Pharmacies) market in Cyprus is also influenced by local special circumstances. Cyprus has a high prevalence of chronic wounds, such as diabetic foot ulcers, due to the aging population and the high incidence of diabetes. This has created a significant demand for specialized wound care products that can effectively manage and heal chronic wounds. As a result, pharmacies in Cyprus are increasingly stocking a wide range of wound care products to cater to the specific needs of their customers. Underlying macroeconomic factors are also contributing to the development of the Wound Care (Pharmacies) market in Cyprus. The country's healthcare system is well-developed, with a strong emphasis on primary care and community-based healthcare services. This has led to the establishment of a robust network of pharmacies across the country, making wound care products easily accessible to the population. Additionally, the government of Cyprus has implemented policies to promote the use of generic medicines, which has made wound care products more affordable for consumers. In conclusion, the Wound Care (Pharmacies) market in Cyprus is developing in response to customer preferences for convenient and accessible healthcare products. The shift towards self-care and the emphasis on quality and efficacy are driving the demand for innovative wound care solutions. Local special circumstances, such as the high prevalence of chronic wounds, further contribute to the growth of the market. The underlying macroeconomic factors, including a well-developed healthcare system and government policies, also play a significant role in shaping the market dynamics.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)